George Lawrence Mikan III Sells 12,440 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 12,440 shares of NeueHealth stock in a transaction on Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the transaction, the chief executive officer now directly owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The shares were sold at an average price of $6.93, for a total value of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The shares were sold at an average price of $7.06, for a total value of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Up 9.4 %

Shares of NYSE NEUE opened at $5.10 on Wednesday. The firm’s 50-day simple moving average is $7.16 and its 200 day simple moving average is $6.01. The company has a market cap of $42.25 million, a price-to-earnings ratio of -0.10 and a beta of 0.56. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in NEUE. Virtu Financial LLC acquired a new position in NeueHealth during the 4th quarter valued at about $76,000. Northern Trust Corp lifted its position in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Finally, Partners Group Holding AG acquired a new position in NeueHealth during the 3rd quarter valued at about $463,000. 63.88% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.